THERAPY OF CHRONIC MYELOID-LEUKEMIA - PROGNOSTIC CRITERIA

Most informative, practicable clinical, morphological and histomorphological criteria have been identified characterizing the stage of clinical evolution of chronic myeloid leukemia (CML) by the time of its diagnosis. Such criteria can be utilized for featuring the risk of short- and long-term CML aggravation. The patients at risk of the disease acceleration are recognized, the survival for various risk groups is analyzed. By a complex of significant signs the patients may be diagnostically classified as being at standard, moderate and high risk.